SCHEMBL32665295

SCHEMBL32665295

CC(C)(C)OC(=O)N[C@H]1CCN(c2cccc(OCc3ccccc3)c2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
CKS1B P61024 1/20 0.48
SKP1 P63208 1/20 0.48
SKP2 Q13309 1/20 0.48
KMT2A Q03164 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
BTK Q06187 1/20 0.46
PIM1 P11309 1/20 0.46
PIM3 Q86V86 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
F10 P00742 1/20 0.46
EPHX2 P34913 1/20 0.45
PDE10A Q9Y233 1/20 0.45
SUV39H2 Q9H5I1 4/20 0.44
SLC6A5 Q9Y345 1/20 0.44
KCNA3 P22001 1/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSK P43235 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665614 1.00 MTNR1A (0.51) MTNR1AMTNR1BCKS1BSKP1SKP2
SCHEMBL3893845 0.94 KMT2A (0.48) MTNR1AMTNR1BKMT2AL3MBTL1BTK
SCHEMBL32665202 0.94 CKS1B (0.52) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL32665123 0.90 ACACB (0.52) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL27451694 0.86 CKS1B (0.53) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL8049478 0.84 MTNR1A (0.66) MTNR1AMTNR1BBTKPIM1PIM3
SCHEMBL23500781 0.84 CKS1B (0.56) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL15222937 0.84 CKS1B (0.56) CKS1BSKP1SKP2KMT2AL3MBTL1
SCHEMBL32665560 0.84 RET (0.44) KMT2AL3MBTL1F10USP2MAPT
SCHEMBL12321963 0.84 CKS1B (0.53) CKS1BSKP1SKP2KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A MTNR1A 1595/4885MTNR1B 2143/4885CKS1B 532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.